Biotron publishes SARS research
Thursday, 11 November, 2004
The researchers at Biotron and the John Curtin School of Medical Research at ANU showed that the SARS coronavirus E protein forms ion channels.
Based on the research, Biotron has developed a screening test for the E protein and has screened its compound library for activity against the SARS E protein as well as other members of the coronavirus family, which are responsible for about 25 per cent of colds as well as other diseases. The company has identified a number of compounds with good activity, which are able to inhibit the replication of the SARS virus.
The work has been supported by a Commonwealth government BIF grant awarded to Biotron in November last year to support the development of the company's Virion platform technology.
3D-printed films provide targeted liver cancer treatment
Researchers have created drug-loaded, 3D-printed films that kill more than 80% of liver cancer...
Using your brain at work may ward off cognitive impairment
The harder your brain works at your job, the less likely you may be to have memory and thinking...
Repurposed drugs show promise in heart muscle regeneration
The FDA-approved medications, when given in combination, target two proteins that regulate the...